Free Trial

Cannabis Stocks To Follow Today - June 20th

Quantum Biopharma logo with Medical background

Quantum Biopharma, Aurora Cannabis, and Turning Point Brands are the three Cannabis stocks to watch today, according to MarketBeat's stock screener tool. Error: Response status code does not indicate success: 429 (Too Many Requests). These companies had the highest dollar trading volume of any Cannabis stocks within the last several days.

Quantum Biopharma (QNTM)

Quantum Biopharma Ltd. is a biotechnology pharmaceutical research and development company, which focuses on the cultivation, process, and sale of medical cannabis. It operates through the Biotechnology and Strategic Investments segments. The Biotechnology segment is involved in the research and development of the company's three drug candidates consisting of FSD-PEA, Lucid-PSYCH, and Lucid-MS.

Shares of Quantum Biopharma stock traded up $5.82 during midday trading on Friday, reaching $36.00. 516,715 shares of the company's stock traded hands, compared to its average volume of 945,510. Quantum Biopharma has a 52 week low of $2.70 and a 52 week high of $37.05. The company's 50 day simple moving average is $11.65 and its 200 day simple moving average is $7.58. The company has a market cap of $97.42 million, a price-to-earnings ratio of -2.21 and a beta of 0.55.

Read Our Latest Research Report on QNTM

Aurora Cannabis (ACB)

Aurora Cannabis Inc., together with its subsidiaries, produces, distributes, and sells cannabis and cannabis-derivative products in Canada and internationally. It operates through three segments: Canadian Cannabis, European Cannabis, and Plant Propagation. The company produces, distributes, and sells medical and consumer cannabis products in Canada.

ACB stock traded down $0.52 during mid-day trading on Friday, reaching $4.17. 2,727,601 shares of the stock traded hands, compared to its average volume of 1,553,747. The firm has a market capitalization of $234.11 million, a PE ratio of 37.95 and a beta of 1.82. The business has a 50-day moving average of $5.06 and a two-hundred day moving average of $4.74. Aurora Cannabis has a 52 week low of $3.42 and a 52 week high of $7.20. The company has a quick ratio of 1.60, a current ratio of 3.30 and a debt-to-equity ratio of 0.07.

Read Our Latest Research Report on ACB

Turning Point Brands (TPB)

Turning Point Brands, Inc., together with its subsidiaries, manufactures, markets, and distributes branded consumer products. The company operates through three segments: Zig-Zag Products, Stoker's Products, and Creative Distribution Solutions. Zig-Zag Products segment markets and distributes rolling papers, tubes, finished cigars, make-your-own cigar wraps, and related products, as well as lighters and other accessories under the Zig-Zag brand.

Shares of NYSE TPB traded up $0.63 during trading hours on Friday, hitting $75.06. 137,534 shares of the company's stock were exchanged, compared to its average volume of 183,434. The stock has a market capitalization of $1.34 billion, a price-to-earnings ratio of 32.92 and a beta of 0.76. The company's 50-day moving average price is $68.83 and its 200-day moving average price is $63.80. The company has a debt-to-equity ratio of 1.44, a current ratio of 4.42 and a quick ratio of 2.64. Turning Point Brands has a 1-year low of $31.45 and a 1-year high of $81.16.

Read Our Latest Research Report on TPB

Featured Articles

This instant news alert was generated by narrative science technology and financial data from MarketBeat in order to provide readers with the fastest and most accurate reporting. This story was reviewed by MarketBeat's editorial team prior to publication. Please send any questions or comments about this story to contact@marketbeat.com.

Should You Invest $1,000 in Quantum Biopharma Right Now?

Before you consider Quantum Biopharma, you'll want to hear this.

MarketBeat keeps track of Wall Street's top-rated and best performing research analysts and the stocks they recommend to their clients on a daily basis. MarketBeat has identified the five stocks that top analysts are quietly whispering to their clients to buy now before the broader market catches on... and Quantum Biopharma wasn't on the list.

While Quantum Biopharma currently has a Hold rating among analysts, top-rated analysts believe these five stocks are better buys.

View The Five Stocks Here

20 High-Yield Dividend Stocks that Could Ruin Your Retirement Cover

Almost everyone loves strong dividend-paying stocks, but high yields can signal danger. Discover 20 high-yield dividend stocks paying an unsustainably large percentage of their earnings. Enter your email to get this report and avoid a high-yield dividend trap.

Get This Free Report
Like this article? Share it with a colleague.

Featured Articles and Offers

Recent Videos

The Drone Industry Is About to 10X—Here’s How to Profit
Why AMD Stock Beats NVIDIA Right Now
Oil Spikes Amid Rising Warfare: 3 Stocks to Watch Now

Stock Lists

All Stock Lists

Investing Tools

Calendars and Tools

Search Headlines